{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:33:49Z","timestamp":1777318429365,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.leukres.2004.01.009","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T10:51:45Z","timestamp":1081594305000},"page":"987-990","source":"Crossref","is-referenced-by-count":42,"title":["First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients"],"prefix":"10.1016","volume":"28","author":[{"given":"Pier Paolo","family":"Piccaluga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Rondoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Malagola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Gaitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Visani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.leukres.2004.01.009_BIB1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.leu.2401539","article-title":"Treatment of acute myelogenous leukemia in older adults","volume":"14","author":"Rowe","year":"2000","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.leukres.2004.01.009_BIB2","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1200\/JCO.2001.19.13.3244","article-title":"Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse","volume":"19","author":"Sievers","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2004.01.009_BIB3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.leu.2402677","article-title":"Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)","volume":"16","author":"Larson","year":"2002","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2004.01.009_BIB4","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.leukres.2004.01.009_BIB5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00280-002-0546-z","article-title":"Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia","volume":"51","author":"Alvarado","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.leukres.2004.01.009_BIB6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-002-0539-y","article-title":"Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia","volume":"50","author":"Cortes","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.leukres.2004.01.009_BIB7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/cncr.11239","article-title":"Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes","volume":"97","author":"Tsimberidou","year":"2003","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.leukres.2004.01.009_BIB8","first-page":"1114","article-title":"Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy","volume":"87","author":"Giles","year":"2002","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.leukres.2004.01.009_BIB9","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1182\/blood-2003-05-1620","article-title":"A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia","volume":"102","author":"Kell","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2004.01.009_BIB10","first-page":"ECR37","article-title":"Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly","volume":"88","author":"Piccaluga","year":"2003","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T04:50:38Z","timestamp":1550119838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0145212604000402"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.01.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}